Gene-edited wheat could slash cancer risk in toast

Forget sourdough starters and artisan loaves – the future of bread might lie in a lab. Scientists in the UK have engineered wheat that dramatically reduces the formation of acrylamide, a probable carcinogen, when toasted, fried, or baked. The breakthrough, achieved through precise gene editing, could reshape how we consume one of humanity’s oldest staples.

A chemical culprit in every slice

The problem, it turns out, isn’t the wheat itself, but a naturally occurring amino acid called free asparagine. As bread cooks, this compound transforms into acrylamide, a substance classified by scientists as a probable human carcinogen. Conventional breeding techniques have attempted to tackle this issue, but often at a cost.

Researchers at Rothamsted Research, leveraging the Crispr genome editing technology, have achieved a far more targeted solution. Crispr, adapted from bacterial systems, allows for incredibly precise alterations to DNA. Their approach focused on the gene responsible for asparagine production, reducing it by a staggering 59% - and up to 93% in a dual-edited line – all without sacrificing crop yields. The comparison with traditional breeding methods is striking: those approaches achieve a 50% reduction in asparagine, but with a hefty 25% yield penalty due to unintended mutations.

“This work demonstrates the power of Crispr technology to deliver precise, beneficial changes in crop genetics,” stated Dr. Navneet Kaur, a lead researcher from Rothamsted. But the regulatory landscape adds another layer of complexity.

Brexit & the precision breeding act

The UK’s departure from the EU has created a unique opportunity for gene-editing research, freeing it from the EU's stricter regulations on genetically modified organisms. The 2023 Genetic Technology (Precision Breeding) Act aims to streamline the development and marketing of gene-edited crops. However, ongoing negotiations with the EU over sanitary and phytosanitary (SPS) agreements pose a significant threat. A dynamic alignment with EU food rules, without a carve-out for precision-bred crops, could severely hinder the UK’s progress.

Meanwhile, the EU itself is tightening regulations on acrylamide levels in food, potentially leading to bans on certain breads exported from both the UK and other nations. Low-acrylamide wheat, therefore, isn't just about consumer health—it's about maintaining market access.

Professor Nigel Halford, who led the study, succinctly put it: “Low-acrylamide wheat could enable food businesses to meet evolving safety standards without compromising product quality or incurring major production costs.” The implications extend beyond just bread and biscuits; it’s a potential solution for a widespread food safety concern, quietly simmering in kitchens around the world.